Study of Efficacy of BZ019 in Large B-cell Lymphoma

Clinical trial NCT05472610 · UNKNOWN

Trial details

NCT number: NCT05472610
Sponsor: Shanghai Mengchao Cancer Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Large B-cell Lymphoma

Start date: 2021-06-04
Primary completion: 2023-01-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.